Creekside Internal Medicine Pc is categorized under Internal Medicine Doctors in Grand Rapids, MI and active since 2007.
Creekside Internal Medicine Pc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Khan Khan at the company’s single location by writing to 334 68th St Sw, Grand Rapids, Michigan MI 49548 or by phoning (616) 281-0547. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Creekside Internal Medicine Pc |
| Contact Person: | Khan Khan |
| Address: | 334 68th St Sw, Grand Rapids, Michigan 49548 |
| Phone Number: | (616) 281-0547 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Creekside Internal Medicine Pc was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Khan Khan for inquiries that concern Creekside Internal Medicine Pc by calling the company number (616) 281-0547, as your correspondence is most welcome. Additionally, the physical location of the single location of Creekside Internal Medicine Pc can be found at the coordinates 42.840713,-85.672459 as well as the street address 334 68th St Sw in Grand Rapids, Michigan 49548.
For its online presence, you may visit Creekside Internal Medicine Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.